Differences in pulmonary and extra-pulmonary traits between women and men with COPD

• Autor(a) principal: Souto-Miranda, S.
• Data de Publicação: 2022
• Outros Autores: Van ‘t Hul, A. J., Vaes, A. W., Antons, J. C., Djamin, R. S., Janssen, D. J., Franssen, F. M., Marques, Alda, Spruit, M. A.
• Idioma: eng
• Título da fonte: Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)
• Texto Completo: http://hdl.handle.net/10773/36273
• topic: COPD; Extrapulmonary impact; Personalised medicine

Background: Prevalence of COPD is similar for women and men. Whether sex-related differences exist in the prevalence of treatable traits is unclear. Aim: To explore sex-related differences in treatable traits in COPD. Methods: Two independent samples of patients with COPD referred to secondary (n=530) or tertiary care (n=2012) were analysed retrospectively. Male and female patients were matched for age, FEV1 and body mass index. Internationally accepted cut-offs were applied to identify the presence of traits. Sex-related differences were tested using independent samples t-tests, Mann-Whitney U or chi-square tests. Results: Frequent exacerbations, high cardiovascular risk and activity-related severe dyspnoea were more prevalent in women than men referred to secondary care (p<0.05). In tertiary care, severe hyperinflation, limited diffusing capacity, impaired mobility, frequent exacerbations, frequent hospitalisations, activity-related severe dyspnoea, symptoms of anxiety and depression, and poor health status were more prevalent in women (p<0.05) and severe inspiratory muscle weakness and impaired exercise capacity were more prevalent among men (p<0.05) (Fig. 1). No other significant differences in traits were found. Conclusions: Sex-related differences were found in pulmonary and extra-pulmonary traits in COPD, with most traits being more prevalent among women. Clinicians should be aware of these differences to adjust treatment.